Zacks Investment Management Lantheus Holdings, Inc. Transaction History

Zacks Investment Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$58.87 - $83.05 $165,601 - $233,619	2,813 Added 22.24%	15,462 $1.24 Million
Q1 2024 May 15, 2024	BUY	$51.07 - $68.26 $645,984 - $863,420	12,649 New	12,649 $787,000
Q1 2023 May 15, 2023	BUY	$47.76 - $82.86 $165,010 - $286,281	3,455 New	3,455 $285,000
Q3 2022 Nov 14, 2022	BUY	$61.42 - $86.29 $4.06 Million - $5.7 Million	66,081 New	66,081 $4.65 Million

545

70M

673K

454K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $5.63B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.